Cancer Registry Software Market Analysis

Cancer Registry Software Market Analysis

To get key market trends

  Download Free Sample

Based on product type, the cancer registry software market is segmented into standalone software and integrated software. The standalone software segment will grow at 10% CAGR to reach USD 143.7 million by 2032.The standalone software is cost-effective, flexible, provides easy integration and data security. The use of standalone software is increasing in the healthcare industry mainly due to the industry’s changing landscape, the need to streamline and optimize workflows and decrease physician workloads.
 

Based on delivery mode, the cancer registry software market is segmented into on-premise and cloud-based. The on-premise segment is expected to grow at CAGR of 10.1% by 2032. The on-premise cancer registry software is mostly adopted by research institutes who are doing research on cancer as they deal with sensitive and confidential data for conducting research and the on-premise cancer registry software implement robust data security measures. The on-premise cancer registry software is embedded with advanced features which help to store data easily. The on-premise cancer registry software is less risky in terms of data security as compared to other types of models. The on-premise cancer registry software allows the organization to organization to implement their own security protocols and measures.
 

The cloud-based cancer registry software can be integrated with the real time data and standard guidelines. This software helps in the reduction of information technology overhead costs. In addition, the cloud-based cancer registry software is efficient in nature.
 

Based on database, the cancer registry software market is segmented into commercial database and public database. The commercial database segment accounted for highest market share of 72.5% in 2022. The data stored in the commercial database is quite safe as compared to public database and it can be easily tracked and used across research centres and government agencies.
 

The public database is used for the various cancer research programs. The utilization of public database is growing due to the increasing number of research centres all over the globe. The public database can help to track patient data from any corner of the world.
 

Based on functionality, the cancer registry software market is segmented into cancer reporting, patient care management, medical research and clinical studies, and product outcome evaluation. In 2022, the cancer reporting segment was valued to be USD 30. million. This functionality allows cancer registries to collect and manage the data on cancer cases to state and federal agencies. The incidence and deaths caused by cancer in a population is monitored using these data. It facilitates the cancer registries and healthcare organizations for collecting, analyzing, and reporting precise and standardized data, resulting in improved cancer care, advancements in research, and public health decision-making.
 

Based on end-user, the cancer registry software market is segmented into government organizations & third-party administration, research institutes, hospital & medical practices, private players, and pharmaceutical, biotech, & medical device companies. The government organizations and third-party administration segment is expected to grow at a CAGR of 10% by 2032. This software helps to track and monitor cancer patients in their respective region. In addition, the increased investments, and initiatives by government for the implementation of cancer registry software in hospitals.
 

The North America cancer registry software marketaccounted for market share of 51.6% in 2022. The industry in this region is growing due to the rising prevalence of cancer, well-developed healthcare infrastructure, increasing investments by government, and the growing demand for cancer registry software.
 

On the other hand, Asia-Pacific is anticipated to experience the fastest expansion by 2032. The governments of developing countries like China and Japan are constantly working to develop the market for cancer registry software.